ADAR1 CAPITAL MANAGEMENT, LLC purchased 26.8% of their position (1.03M shares) of TENAX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.81M — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/24/2026ACC: 0001940272-26-000017
10% Owner
Since Aug 2026
+1.03M
Net shares
Net buyer
$1.81M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
1.03M acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+202.12K
Price / share
$1.78
Trade value
$359.54K
% of position
5.3%
8/20/2026
3.83M→4.03M
Common Stock
Indirect
Shares
+716.37K
Price / share
$1.77
Trade value
$1.27M
% of position
17.8%
8/21/2026
4.03M→4.75M
Common Stock
Indirect
Shares
+107.37K
Price / share
$1.75
Trade value
$188.36K
% of position
2.3%
8/24/2026
4.75M→4.85M
Total
Net shares
+1.03M
Net value
$1.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/20/2026 | P · Purchase | +202.12K | $1.78 | $359.54K | 5.3% | 3.83M | 4.03M |
| Common Stock Indirect | 8/21/2026 | P · Purchase | +716.37K | $1.77 | $1.27M | 17.8% | 4.03M | 4.75M |
| Common Stock Indirect | 8/24/2026 | P · Purchase | +107.37K | $1.75 | $188.36K | 2.3% | 4.75M | 4.85M |
| Total | +1.03M | $1.81M | ||||||
Derivative Transactions0
No derivative transactions reported